AbbVie, Inc.



$96.30Share Price
$154.4 BMarket Cap
5.6%EBIT / EV
3.6%FCF / EV
12.9%Cash ROIC
11.0%3yr Avg Revenue Growth
1.38Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

check mark The EBIT / Enterprise Value of 5.6% ranks as Average.
x mark The Free Cash Flow / Enterprise Value of 3.6% ranks as Below Average.
check mark The Return on Invested Capital Value of 20.0% ranks as Above Average.
check mark The Cash Return on Capital Value of 12.9% ranks as Above Average.
check mark The 3 Year Average Revenue Growth Value of 11.0% ranks as Above Average.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 1.38.

Company Description

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.


You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.